NATIONAL RECOMMENDATIONS FOR ANTICOAGULANT THROMBOPROPHYLAXIS IN CHILDREN AND ADOLESCENTS WITH SARS-COV-2 INFECTION

Acute SARS-CoV-2 infection may be accompanied by a hypercoagulable state with thromboembolic events, SAR-S-CoV-2-associated coagulopathy, and disseminated intra-vascular coagulation due to activation of the coagulation pathway. Two to six weeks after infection, children may develop a multisystem inﬂ...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Barbara Faganel Kotnik, Alenka Trampuš Bakija, Tadej Avčin, Lidija Kitanovski
Formato:	article
Lenguaje:	SL
Publicado:	The Society for Children with Metabolic Disorders 2021
Materias:	sars-cov-2 anticoagulant prophylaxis children Medicine R Pediatrics RJ1-570
Acceso en línea:	https://doaj.org/article/3a7aed6217df438eb37f699b317dc0ee
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:3a7aed6217df438eb37f699b317dc0ee
record_format	dspace
spelling	oai:doaj.org-article:3a7aed6217df438eb37f699b317dc0ee2021-11-08T17:58:04ZNATIONAL RECOMMENDATIONS FOR ANTICOAGULANT THROMBOPROPHYLAXIS IN CHILDREN AND ADOLESCENTS WITH SARS-COV-2 INFECTION1318-44232712-396010.38031/slovpediatr-2021-3-02enhttps://doaj.org/article/3a7aed6217df438eb37f699b317dc0ee2021-10-01T00:00:00Z http://www.slovenskapediatrija.si/Portals/0/Clanki/2021/Slovpediatr-2021-3-02en.pdf https://doaj.org/toc/1318-4423https://doaj.org/toc/2712-3960Acute SARS-CoV-2 infection may be accompanied by a hypercoagulable state with thromboembolic events, SAR-S-CoV-2-associated coagulopathy, and disseminated intra-vascular coagulation due to activation of the coagulation pathway. Two to six weeks after infection, children may develop a multisystem inﬂammatory response when the risk of thromboembolic disease is again increased due to widespread vascular endothelial damage and numerous coagulation and inﬂammatory factors. We present national recommendations for pharmacological anticoagulant thromboprophylaxis in children and adolescents with SARS-CoV-2 infection as outpatients, in hospital or in the intensive care unit. Treatment of children and adolescents with congenital bleeding disorders, known congenital thrombophilia and inserted central venous catheter is speciﬁed separately.Barbara Faganel KotnikAlenka Trampuš BakijaTadej AvčinLidija KitanovskiThe Society for Children with Metabolic Disordersarticlesars-cov-2anticoagulant prophylaxischildrenMedicineRPediatricsRJ1-570SLSlovenska pediatrija, Vol 28, Iss 3, Pp 130-137 (2021)
institution	DOAJ
collection	DOAJ
language	SL
topic	sars-cov-2 anticoagulant prophylaxis children Medicine R Pediatrics RJ1-570
spellingShingle	sars-cov-2 anticoagulant prophylaxis children Medicine R Pediatrics RJ1-570 Barbara Faganel Kotnik Alenka Trampuš Bakija Tadej Avčin Lidija Kitanovski NATIONAL RECOMMENDATIONS FOR ANTICOAGULANT THROMBOPROPHYLAXIS IN CHILDREN AND ADOLESCENTS WITH SARS-COV-2 INFECTION
description	Acute SARS-CoV-2 infection may be accompanied by a hypercoagulable state with thromboembolic events, SAR-S-CoV-2-associated coagulopathy, and disseminated intra-vascular coagulation due to activation of the coagulation pathway. Two to six weeks after infection, children may develop a multisystem inﬂammatory response when the risk of thromboembolic disease is again increased due to widespread vascular endothelial damage and numerous coagulation and inﬂammatory factors. We present national recommendations for pharmacological anticoagulant thromboprophylaxis in children and adolescents with SARS-CoV-2 infection as outpatients, in hospital or in the intensive care unit. Treatment of children and adolescents with congenital bleeding disorders, known congenital thrombophilia and inserted central venous catheter is speciﬁed separately.
format	article
author	Barbara Faganel Kotnik Alenka Trampuš Bakija Tadej Avčin Lidija Kitanovski
author_facet	Barbara Faganel Kotnik Alenka Trampuš Bakija Tadej Avčin Lidija Kitanovski
author_sort	Barbara Faganel Kotnik
title	NATIONAL RECOMMENDATIONS FOR ANTICOAGULANT THROMBOPROPHYLAXIS IN CHILDREN AND ADOLESCENTS WITH SARS-COV-2 INFECTION
title_short	NATIONAL RECOMMENDATIONS FOR ANTICOAGULANT THROMBOPROPHYLAXIS IN CHILDREN AND ADOLESCENTS WITH SARS-COV-2 INFECTION
title_full	NATIONAL RECOMMENDATIONS FOR ANTICOAGULANT THROMBOPROPHYLAXIS IN CHILDREN AND ADOLESCENTS WITH SARS-COV-2 INFECTION
title_fullStr	NATIONAL RECOMMENDATIONS FOR ANTICOAGULANT THROMBOPROPHYLAXIS IN CHILDREN AND ADOLESCENTS WITH SARS-COV-2 INFECTION
title_full_unstemmed	NATIONAL RECOMMENDATIONS FOR ANTICOAGULANT THROMBOPROPHYLAXIS IN CHILDREN AND ADOLESCENTS WITH SARS-COV-2 INFECTION
title_sort	national recommendations for anticoagulant thromboprophylaxis in children and adolescents with sars-cov-2 infection
publisher	The Society for Children with Metabolic Disorders
publishDate	2021
url	https://doaj.org/article/3a7aed6217df438eb37f699b317dc0ee
work_keys_str_mv	AT barbarafaganelkotnik nationalrecommendationsforanticoagulantthromboprophylaxisinchildrenandadolescentswithsarscov2infection AT alenkatrampusbakija nationalrecommendationsforanticoagulantthromboprophylaxisinchildrenandadolescentswithsarscov2infection AT tadejavcin nationalrecommendationsforanticoagulantthromboprophylaxisinchildrenandadolescentswithsarscov2infection AT lidijakitanovski nationalrecommendationsforanticoagulantthromboprophylaxisinchildrenandadolescentswithsarscov2infection
_version_	1718441462078636032

NATIONAL RECOMMENDATIONS FOR ANTICOAGULANT THROMBOPROPHYLAXIS IN CHILDREN AND ADOLESCENTS WITH SARS-COV-2 INFECTION

Ejemplares similares